News

Buy Sequent Scientific Ltd For Target Rs.95 - Yes Securities Result Synopsis Sequent reported another disappointing quarter as one-off related to inventory write down, German plant closure amongst others led to large margin miss; topline struggled in face of demand issues in Turkey, Europe in formulations while API grapples with pricing pressures and forex challenges. Adjusted for one-offs, reckon margin would still be in the 6-6.5% range vs reported ~2.7% and ~7.5% in Q3, implying further worsening of underlying business. Lack of margin recovery...
Buy Sequent Scientific Ltd For Target Rs.95 - Yes Securities
Buy Sequent Scientific Ltd For Target Rs.95 - Yes Securities
Source: Yes Securities
16/06/2023 1:10:06 PM
Sequent Scientific zooms on the BSE Sequent Scientific is currently trading at Rs. 83.79, up by 9.42 points or 12.67% from its previous closing of Rs. 74.37 on the BSE. The scrip opened at Rs. 75.31 and has touched a high and low of Rs. 84.40 and Rs. 75.31 respectively. So far 1353896 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 155.90 on 06-Apr-2022 and a 52 week low of Rs. 61.80 on 08-Mar-2023. Last one week high and low of the scrip stood at...
Sequent Scientific zooms on the BSE
Sequent Scientific zooms on the BSE
Source: Accord Fintech
10/03/2023 12:25:57 PM
Sequent Scientific shines after terminating share purchase agreement with Tineta Sequent Scientific is currently trading at Rs. 73.63, up by 11.25 points or 18.03% from its previous closing of Rs. 62.38 on the BSE. The scrip opened at Rs. 62.84 and has touched a high and low of Rs. 74.70 and Rs. 62.84 respectively. So far 1472066 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 155.90 on 06-Apr-2022 and a 52 week low of Rs. 61.80 on 08-Mar-2023. Last one week high and low of the scrip stood a...
Sequent Scientific shines after terminating share purchase agreement with Tineta
Sequent Scientific shines after terminating share purchase agreement with Tineta
Source: Accord Fintech
9/03/2023 3:31:43 PM
Buy Sequent Scientific Ltd For Target Rs.130 - Yes Securities Margin recovery delayed but may not be denied   Result Synopsis Sequent continued with sequential recovery after what is likely to be a bottom for revenues in Q1 FY23 with sales up 11% QoQ and ~5% YoY. API business rebounded with ~13.5% cc growth QoQ though YoY still down ~3% as customers still appear cautious in inventory replenishment. Europe continues to be plagued with demand issue compared to last year run rate though QoQ recovery is visible with ~11% rise in sales. Currenc...
Buy Sequent Scientific Ltd For Target Rs.130 - Yes Securities
Buy Sequent Scientific Ltd For Target Rs.130 - Yes Securities
Source: Yes Securities Ltd
16/02/2023 2:25:53 PM
Buy Sequent Scientific Ltd For Target Rs.140 - Yes Securities Bouncing along the troughs Result Synopsis Sequent reported yet another disappointing quarter with revenue decline on YoY and QoQ basis. In cc terms, revenues grew 3% as API business was subdued due to slower demand and delays in conclusion of few contracts; formulations business grew 15% in constant currency driven by strong performance in emerging markets and India. Albeit, Turkey continues to be a pain point upon translation while Europe presented additional risk due to high energy c...
Buy Sequent Scientific Ltd For Target Rs.140 - Yes Securities
Buy Sequent Scientific Ltd For Target Rs.140 - Yes Securities
Source: Yes Securities Ltd
31/12/2022 2:08:59 PM
Buy Sequent Scientific Ltd For Target Rs.210 - Yes Securities Worst of margin woes may be behind Result Synopsis Sequent clocked a steady growth quarter with 11-12% growth across API and formulations businesses while margin did improve on sequential basis as higher margin API share increased ~200bps QoQ. Management expects to implement price increase at least in some part of long term contracts whose benefit would be gradually seen over course of FY23. API business rebounded on weak 3Q base as expected though still fell short of expectations. N...
Buy Sequent Scientific Ltd For Target Rs.210 - Yes Securities
Buy Sequent Scientific Ltd For Target Rs.210 - Yes Securities
Source: Yes Securities Ltd
27/05/2022 10:48:02 AM
Buy Sequent Scientific Ltd For Target Rs.260 - Yes Securities Margin to follow revenue recovery Our view Apollo Hospitals ARPOB continue to gain traction with 14% increase on a blended basis in 9m FY22; a look at the ARPOB increase within some of the clusters (accounting for ~40% of cumulative operating beds) shows even faster increase on a 2-year CAGR basis at 15-19% (without international traffic in 9m FY22 carrying better embedded realization in the historical base). This shows the impact of mix change in the hospitals business over last 18 mon...
Buy Sequent Scientific Ltd For Target Rs.260 - Yes Securities
Buy Sequent Scientific Ltd For Target Rs.260 - Yes Securities
Source: Yes Securities Ltd
14/02/2022 10:21:58 AM
Key News - Indian Oil Corporation Ltd , Oil India Ltd , Metro Shoes Ltd, HDFC Bank Ltd , HCL Technologies Ltd By ARETE Securities Key News IOC to invest Rs 7,000 cr in city gas after it secures 33% market areas. Indian Oil Corporation (IOC), the nation's largest oil firm, on Sunday said it will invest over Rs 7,000 crore in setting up city gas distribution networks in the cities for which it has secured a licence in the latest bidding round.. IOC secured 33 per cent of the demand potential that was up for grabs in the recently concluded 11th round of CGD bidding, cornering cities from Jammu to Madurai to Ha...
Key News - Indian Oil Corporation Ltd , Oil India Ltd , Metro Shoes Ltd, HDFC Bank Ltd , HCL Technologies Ltd By ARETE Securities
Key News - Indian Oil Corporation Ltd , Oil India Ltd , Metro Shoes Ltd, HDFC Bank Ltd , HCL Technologies Ltd By ARETE Securities
Source: ARETE Securities Ltd
17/01/2022 9:34:31 AM
Buy Sequent Scientific Ltd For Target Rs.280 - Yes Securities Our view Sequent Scientific made a sequential comeback across API business with 21% QoQ growth though still down 10% YoY. Formulations also saw 8% rise driven by Lat Am and Europe while Turkey was impacted by currency depreciation (local currency sales clocked double digit growth). Demand scenario is set to pick up in API driven by 1) increase in customer buying 2) gradual reopening of schools in H2 benefiting Albendazole business and 3) order execution for a top 10 animal health customer....
Buy Sequent Scientific Ltd For Target Rs.280 - Yes Securities
Buy Sequent Scientific Ltd For Target Rs.280 - Yes Securities
Source: Yes Securities Ltd
7/11/2021 12:26:59 PM
Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244 - HDFC Securities Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244  - HDFC Securities After showing sideways range movement in the last few weeks, the stock price has shifted into an upside bounce in this week. Presently, the stock price is making an attempt to stage upside breakout of the crucial overhead resistance around Rs 225 levels. Hence, a sustainable move above this area could open a sharp upside breakout. The down trend of the last few months s...
Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244 - HDFC Securities
Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244 - HDFC Securities
Source: HDFC Securities Ltd
13/10/2021 2:24:43 PM
Update On Sequent Scientific Ltd By Monarch Networth Capital Key MeetingTakeaways Sequent 2.0: * Shift in gear for the company as it embarks journey towards Sequent 2.0 wherein focus areas for the company would be value added products and further penetration in geographies such as US, Europe and in Asia with increased focus on customer demand. * Focus on sterile injectable for growth in phase 2.0. * Emphasis on farm animals over companion animals. * No plans of getting into vaccines. * Within the API segment: no plans of getting into fer...
Update On Sequent Scientific Ltd By Monarch Networth Capital
Update On Sequent Scientific Ltd By Monarch Networth Capital
Source: Monarch Networth Capital Ltd
20/08/2021 12:33:12 PM
Momentum Pick - Buy Sequent Scientific Ltd For Target Rs. 320 - HDFC Securities Momentum Pick - Buy  Sequent Scientific Ltd For Target Rs. 320- HDFC Securities  Stock price has broken out on the Daily chart with higher volumes. Oscillators like MFI & RSI is showing strength in the current uptrend of the stock Short term trend of the stock has turned positive where stock price closed above its 5- and 20-day SMA. Primary trend of stock is positive where stock is trading above its 200 day SMA Buy Sequent Scientific L...
Momentum Pick - Buy Sequent Scientific Ltd For Target Rs. 320 - HDFC Securities
Momentum Pick - Buy Sequent Scientific Ltd For Target Rs. 320 - HDFC Securities
Source: HDFC Securities Ltd
7/05/2021 12:23:01 PM
Sequent Scientific Q3 net profit zooms 316.78% at Rs 12.17 cr The company reported standalone net profit of Rs 12.17 crore for the quarter ended December 31, 2020 as compared to Rs 2.92 crore in the same period last year, registering a year-on-year growth of 316.78 per cent. Net revenue of the company rose moderately by 14.19 per cent at Rs 70.57 crore in October-December quarter of this fiscal as against Rs 61.80 crore in the corresponding period last year. During October-December quarter, operatin...
Sequent Scientific Q3 net profit zooms 316.78% at Rs 12.17 cr
Sequent Scientific Q3 net profit zooms 316.78% at Rs 12.17 cr
Source: IANS
4/02/2021 12:01:16 PM